Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?

This publication has 15 references indexed in Scilit:

• Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85
  Radiotherapy and Oncology, 1991
• Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations
  Radiotherapy and Oncology, 1991
• A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments
  Radiotherapy and Oncology, 1991
• Response of the mouse mediastinum to single and fractionated X-rays
  The British Journal of Radiology, 1991
• The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo
  Radiotherapy and Oncology, 1990
• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Intracapillary oxyhemoglobin saturation of malignant tumors in humans
  International Journal of Radiation Oncology*Biology*Physics, 1981
• A review of hypoxic cell radiosensitization in experimental tumors
  Pharmacology & Therapeutics, 1979
• Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation
  The British Journal of Radiology, 1979